Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: FRExchange: Nasdaq
DilutionScan read 29 of Cellectis S.A.'s SEC filings and found 4 warrant series, 2 convertibles and 2 shelf registrations on file for CLLS. The latest dilution event on file is a registration statement on Jul 11, 2025. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CRBPCorbus Pharmaceuticals Holdings, Inc.
OKYOOKYO Pharma Limited Ordinary Shares
COYACoya Therapeutics, Inc.
NTRBNutriband Inc.
MNOVMediciNova, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
TELOTelomir Pharmaceuticals, Inc. Common Stock
NRXSNeurAxis, Inc.
CSBRChampions Oncology, Inc.
CINGCingulate Inc.
TENXTenax Therapeutics, Inc.
MAIAMAIA Biotechnology, Inc.
TNYATenaya Therapeutics, Inc.
NMADNOMAD Power Solutions, Inc.
CRDFCardiff Oncology, Inc.